These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2491469)

  • 21. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.
    Biemond I; Crobach LF; Jansen JB; Lamers CB
    Eur J Clin Pharmacol; 1989; 37(4):345-9. PubMed ID: 2598968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
    Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
    J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.
    Feldman M; Cryer B; Sammer D; Lee E; Spechler SJ
    Am J Physiol; 1999 Dec; 277(6):G1159-64. PubMed ID: 10600812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of omeprazole on gastric acid secretion in man.
    Olbe L; Lind T; Cederberg C; Ekenved G
    Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
    Brummer RJ; Geerling BJ; Stockbrügger RW
    Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
    Simon B; Müller P; Hartmann M; Bliesath H; Lühmann R; Huber R; Bohnenkamp W; Wurst W
    Z Gastroenterol; 1990 Sep; 28(9):443-7. PubMed ID: 2177296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF; Fraser R; Armstrong D; Blum AL
    Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis.
    Kovacs TO; Lee CQ; Chiu YL; Pilmer BL; Metz DC
    Aliment Pharmacol Ther; 2004 Oct; 20(8):883-9. PubMed ID: 15479360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
    Otani Y; Kitajima M; Sugiyama M; Watanabe Y; Aoki T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S22-6. PubMed ID: 7594333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole.
    Hussein Z; Granneman GR; Mukherjee D; Samara E; Hogan DL; Koss MA; Isenberg JI
    Br J Clin Pharmacol; 1993 Nov; 36(5):391-8. PubMed ID: 12959285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous lansoprazole: in erosive oesophagitis.
    Dando TM; Plosker GL
    Drugs; 2004; 64(18):2085-9; discussion 2090. PubMed ID: 15341501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole.
    Freston JW; Pilmer BL; Chiu YL; Wang Q; Stolle JC; Griffin JS; Lee CQ
    Aliment Pharmacol Ther; 2004 May; 19(10):1111-22. PubMed ID: 15142201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lansoprazole on gastric ulcer healing and mucin content.
    Komuro Y; Ishii K; Miyake Y; Tanabe S; Oida M; Saigenji K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.
    Festen HP; Tuynman HA; Den Hollander W; Meuwissen SG
    Aliment Pharmacol Ther; 1989 Aug; 3(4):375-9. PubMed ID: 2518851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin.
    Crobach LF; Jansen JB; Lamers CB
    Scand J Gastroenterol; 1988 May; 23(4):407-12. PubMed ID: 3381063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.
    Lind T; Cederberg C; Forssell H; Olausson M; Olbe L
    Scand J Gastroenterol; 1988 Dec; 23(10):1259-66. PubMed ID: 3249924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
    Furuta T; Shirai N; Sugimoto M; Nakamura A; Okudaira K; Kajimura M; Hishida A
    Aliment Pharmacol Ther; 2005 Jul; 22(1):67-74. PubMed ID: 15963082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.